HF3452
Kratom classified as a Schedule II controlled substance.
Legislative Session 94 (2025-2026)
Related bill: SF3711
Bill text
(underlined = new law, struck through = current law the bill removes)
1.1A bill for an act
1.2relating to public safety; classifying kratom as a Schedule II controlled substance;
1.3amending Minnesota Statutes 2024, section 152.02, subdivision 3; repealing
1.4Minnesota Statutes 2024, section 152.027, subdivision 7.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6Section 1. Minnesota Statutes 2024, section 152.02, subdivision 3, is amended to read:
1.7Subd. 3. Schedule II. (a) Schedule II consists of the substances listed in this subdivision.
1.8(b) Unless specifically excepted or unless listed in another schedule, any of the following
1.9substances whether produced directly or indirectly by extraction from substances of vegetable
1.10origin or independently by means of chemical synthesis, or by a combination of extraction
1.11and chemical synthesis:
1.12(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
1.13opiate.
1.14(i) Excluding:
1.15(A) apomorphine;
1.16(B) thebaine-derived butorphanol;
1.17(C) dextrophan;
1.18(D) nalbuphine;
1.19(E) nalmefene;
1.20(F) naloxegol;
2.1(G) naloxone;
2.2(H) naltrexone; and
2.3(I) their respective salts;
2.4(ii) but including the following:
2.5(A) opium, in all forms and extracts;
2.6(B) codeine;
2.7(C) dihydroetorphine;
2.8(D) ethylmorphine;
2.9(E) etorphine hydrochloride;
2.10(F) hydrocodone;
2.11(G) hydromorphone;
2.12(H) metopon;
2.13(I) morphine;
2.14(J) oxycodone;
2.15(K) oxymorphone;
2.16(L) thebaine;
2.17(M) oripavine;
2.18(2) any salt, compound, derivative, or preparation thereof which is chemically equivalent
2.19or identical with any of the substances referred to in clause (1), except that these substances
2.20shall not include the isoquinoline alkaloids of opium;
2.21(3) opium poppy and poppy straw;
2.22(4) coca leaves and any salt, cocaine compound, derivative, or preparation of coca leaves
2.23(including cocaine and ecgonine and their salts, isomers, derivatives, and salts of isomers
2.24and derivatives), and any salt, compound, derivative, or preparation thereof which is
2.25chemically equivalent or identical with any of these substances, except that the substances
2.26shall not include decocainized coca leaves or extraction of coca leaves, which extractions
2.27do not contain cocaine or ecgonine;
2.28(5) concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid,
2.29or powder form which contains the phenanthrene alkaloids of the opium poppy).
3.1(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts
3.2of isomers, esters and ethers, unless specifically excepted, or unless listed in another schedule,
3.3whenever the existence of such isomers, esters, ethers and salts is possible within the specific
3.4chemical designation:
3.5(1) alfentanil;
3.6(2) alphaprodine;
3.7(3) anileridine;
3.8(4) bezitramide;
3.9(5) bulk dextropropoxyphene (nondosage forms);
3.10(6) carfentanil;
3.11(7) dihydrocodeine;
3.12(8) dihydromorphinone;
3.13(9) diphenoxylate;
3.14(10) fentanyl;
3.15(11) isomethadone;
3.16(12) levo-alpha-acetylmethadol (LAAM);
3.17(13) levomethorphan;
3.18(14) levorphanol;
3.19(15) metazocine;
3.20(16) methadone;
3.21(17) methadone - intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;
3.22(18) moramide - intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic
3.23acid;
3.24(19) pethidine;
3.25(20) pethidine - intermediate - a, 4-cyano-1-methyl-4-phenylpiperidine;
3.26(21) pethidine - intermediate - b, ethyl-4-phenylpiperidine-4-carboxylate;
3.27(22) pethidine - intermediate - c, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
3.28(23) phenazocine;
4.1(24) piminodine;
4.2(25) racemethorphan;
4.3(26) racemorphan;
4.4(27) remifentanil;
4.5(28) sufentanil;
4.6(29) tapentadol;
4.7(30) 4-Anilino-N-phenethylpiperidine;
4.8(31) oliceridine;
4.9(32) norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide).
4.10(d) Unless specifically excepted or unless listed in another schedule, any material,
4.11compound, mixture, or preparation which contains any quantity of the following substances
4.12having a stimulant effect on the central nervous system:
4.13(1) amphetamine, its salts, optical isomers, and salts of its optical isomers;
4.14(2) methamphetamine, its salts, isomers, and salts of its isomers;
4.15(3) phenmetrazine and its salts;
4.16(4) methylphenidate;
4.17(5) lisdexamfetamine.
4.18(e) Unless specifically excepted or unless listed in another schedule, any material,
4.19compound, mixture, or preparation which contains any quantity of the following substances
4.20having a depressant effect on the central nervous system, including its salts, isomers, and
4.21salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible
4.22within the specific chemical designation:
4.23(1) amobarbital;
4.24(2) glutethimide;
4.25(3) secobarbital;
4.26(4) pentobarbital;
4.27(5) phencyclidine;
4.28(6) phencyclidine immediate precursors:
4.29(i) 1-phenylcyclohexylamine;
5.1(ii) 1-piperidinocyclohexanecarbonitrile;
5.2(7) phenylacetone.
5.3(f) Cannabinoids:
5.4(1) nabilone;
5.5(2) dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in an oral solution
5.6in a drug product approved for marketing by the United States Food and Drug Administration.
5.7 new text begin (g) Unless specifically excepted or unless listed in another schedule, any of the following new text end
5.8 new text begin substances produced directly or indirectly by extraction from substances of vegetable origin new text end
5.9 new text begin or independently by means of chemical synthesis, or by a combination of extraction and new text end
5.10 new text begin chemical synthesis, or their isomers, esters, ethers, salts, and salts of isomers, esters and new text end
5.11 new text begin ethers: new text end
5.12 new text begin (1) mitragynine; new text end
5.13 new text begin (2) 7-hydroxymitragynine. new text end
5.14Sec. 2. new text begin REPEALER. new text end
5.15 new text begin Minnesota Statutes 2024, section 152.027, subdivision 7, is repealed. new text end APPENDIX Repealed Minnesota Statutes: 26-05964 152.027 OTHER CONTROLLED SUBSTANCE OFFENSES. Subd. 7. Sale or possession of kratom. (a) A person who unlawfully sells any amount of kratom or a substance that contains mitragynine or 7-hydroxymitragynine to a person under the age of 18 is guilty of a gross misdemeanor. (b) A person under the age of 18 who unlawfully possesses any amount of kratom or a substance that contains mitragynine or 7-hydroxymitragynine is guilty of a misdemeanor.
Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.
Progress through the legislative process
In Committee
Sponsors
- Rep. Jessica Hanson (DFL)
- Rep. Brad Tabke (DFL)
- Rep. Steve Elkins (DFL)
- Rep. Alexander Falconer (DFL)
- Rep. Ginny Klevorn (DFL)
- Rep. Kristin Robbins (R)
- Rep. Larry Kraft (DFL)
- Rep. Kristin Bahner (DFL)
- Rep. Paul Novotny (R)
- Rep. Heather Keeler (DFL)
- Rep. Jeff Backer (R)
- Rep. Kristi Pursell (DFL)
- Rep. Ben Davis (R)
- Rep. Ben Davis (R)